Clinical utility of different anti-Müllerian hormone – AMH assays for the purpose of pregnancy prediction

References

• Visser JA, Themmen AP. Anti-Müllerian hormone and folliculogenesis. Mol Cell Endocrinol 2005;29:81–6
   Web of Science ®Google Scholar
• Weenen C, Laven JS, Von Bergh AS, et al. Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment”. Mol Hum Reprod 2004;10:77–83
   PubMed Web of Science ®Google Scholar
• Hazout A, Bouchard P, Seifer DB, et al. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol. Fertil Steril 2004;82:1323–9
   PubMed Web of Science ®Google Scholar
• Nelson SM, Yates RW, Lyall H, et al. Anti-Müllerian hormone-based approach to controlled ovarian stimulation for assisted conception. Hum Reprod 2009;24:867–75
   PubMed Web of Science ®Google Scholar
• La Marca A, Sighinolfi G, Radi D, et al. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update 2010;16:113–30
   PubMed Web of Science ®Google Scholar
• Silberstein T, MacLaughlin DT, Shai I, et al. Mullerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology. Hum Reprod 2006;21:159–63
   PubMed Web of Science ®Google Scholar
• Smeenk JM, Sweep FC, Zielhuis GA, et al. Antimüllerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracyoplasmic sperm injection. Fertil Steril 2007;87:223–6
   PubMed Web of Science ®Google Scholar
• Lukaszuk K, Liss J, Kunicki M, et al. Anti-Müllerian hormone (AMH) is a strong predictor of live birth in women undergoing assisted reproductive technology. Reprod Biol 2014;14:176–81
   PubMed Web of Science ®Google Scholar
• Fong SL, Lugtenburg PJ, Schipper I, et al. Anti-mullerian hormone as a marker of ovarian function in women after chemotherapy and radiotherapy for haematological malignancies. Hum Reprod 2008;23:674–8
   PubMed Web of Science ®Google Scholar
• Nelson SM, Yates RW, Fleming R. Serum anti-Mullerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles–implications for individualization of therapy. Hum Reprod 2007;22:2414–21
   PubMed Web of Science ®Google Scholar
• Nardo LG, Christodoulou D, Gould D, et al. Anti-Mu¨llerian hormone levels andantral follicle count in women enrolled in in vitro fertilization cycles: relationship to lifestyle factors, chronological age and reproductive history. Gynecol Endocrinol 2007;23:486–93
   PubMed Web of Science ®Google Scholar
• Nardo LG, Gelbaya TA, Wilkinson H, et al. Circulating basal anti-Mullerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization. Fertil Steril 2009;92:1586–93
   PubMed Web of Science ®Google Scholar
• Lee RK, Wu FS, Lin MH, et al. The predictability of serum anti-Müllerian level in IVF/ICSI outcomes for patients of advanced reproductive age. Reprod Biol Endocrinol 2011;9:115
   PubMed Web of Science ®Google Scholar
• La Marca A, Nelson SM, Sighinolfi G, et al. Anti-Müllerian hormone-based prediction model for a live birth in assisted reproduction. Reprod Biomed. Online 2011;22:341–9
   PubMed Web of Science ®Google Scholar
• Lukaszuk K, Kunicki M, Liss J. Use of ovarian reserve parameters for predicting live births in women undergoing in vitro fertilization. Eur J Obstet Gynecol Reprod Biol 2013;168:173–7
   PubMed Web of Science ®Google Scholar
• Lukaszuk K, Kunicki M, Liss J, et al. Probability of live birth in women with extremely low anti-Müllerian hormone concentrations. Reprod Biomed Online 2014;28:64–9
   PubMed Web of Science ®Google Scholar
• Nelson SM, Lawlor DA. Predicting live birth, preterm and low birth weight infant after in-vitro fertilisation: a prospective study of 144,018 treatment cycles. PLoS Med 2011;8:e1000386
   PubMed Web of Science ®Google Scholar
• Hudson PL, Dougas I, Donahoe PK, et al. An immunoassay to detect human Mullerian inhibiting substance in males and females during normal development. J Clin Endocrinol Metab 1990;70:16–22
   PubMed Web of Science ®Google Scholar
• Fréour T, Mirallié S, Bach-Ngohou K, et al. Measurement of serum anti-Müllerian hormone by Beckman Coulter ELISA and DSL ELISA: comparison and relevance in assisted reproduction technology (ART). Clin Chim Acta 2007;375:162–4
   PubMed Web of Science ®Google Scholar
• Taieb J, Belville C, Coussieu C, et al. Two immunoassays for antimullerian hormone measurement: analytical and clinical performances. Ann Biol Clin 2008;5:537–47
   Google Scholar
• Practice Committee. Society for Assisted Reproductive Medicine and the American Society for Reproductive Medicine. Guidelines on the number of embryos transferred: a practice committee report. Fertil Steril 2004;82:772–4
   Web of Science ®Google Scholar
• Streuli I, Fraisse T, Chapron C, et al. Clinical uses of anti-Müllerian hormone assays: pitfalls and promises”. Fertil Steril 2009;91:226–30
   PubMed Web of Science ®Google Scholar
• Bersinger NA, Wunder D, Birkhäuser MH, et al. Measurement of anti-Mullerian hormone by Beckman Coulter ELISA and DSL ELISA in assisted reproduction: differences between serum and follicular fluid. Clin Chim Acta 2007;384:174–5
   PubMed Web of Science ®Google Scholar
• Lee MM, Donahoe PK, Hasegawa T, et al. Mullerian inhibiting substance in humans: normal levels from infancy to adulthood. J Clin Endocrinol Metab 1996;81:571–6
   PubMed Web of Science ®Google Scholar
• Kumar A, Kalra B, Patel A, et al. Development of a second generation anti-Müllerian hormone (AMH) ELISA. J Immunol Methods 2010;362:51–9
   PubMed Web of Science ®Google Scholar
• Li HW, Ng EH, Wong BP, et al. Correlation between three assay systems for anti-Müllerian hormone (AMH) determination. J Assist Reprod Genet 2012;29:1443–6
   PubMed Web of Science ®Google Scholar
• Pigny P, Merlen E, Robert Y, et al. Elevated serum level of anti-Mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. J Clin Endocrinol Metab 2003;88:5957–62
   PubMed Web of Science ®Google Scholar
• Wallace AM, Faye SA, Fleming R, et al. A multicentre evaluation of the new Beckman Coulter anti-Mullerian hormone immunoassay (AMH Gen II). Ann Clin Biochem 2011;48:370–3
   PubMed Web of Science ®Google Scholar
• Rustamov O, Pemberton PW, Roberts SA, et al. The reproducibility of serum anti-Müllerian hormone in subfertile women: within and between patient variability. Fertil Steril 2011;95:1185–7
   PubMed Web of Science ®Google Scholar
• Preissner CM, Morbeck DE, Gada RP. Validation of a second generation assay for anti-Mullerian hormone. Clin Chem 2010;56:A54
   Google Scholar
• Nelson SM, Pastuszek E, Kloss G, et al. Two new automated, compared with two enzyme-linked immunosorbent, antiMüllerian hormone assays. Fertil Steril 2015;104:1016–21
   PubMed Web of Science ®Google Scholar
• Lukaszuk K, Ludwikowska B, Liss J, et al. Decreasing quality of the new generations of anti-Müllerian hormone assays. Biomed Res Int 2014;2014:165352
   PubMed Web of Science ®Google Scholar
• Rustamov O, Smith A, Roberts SA, et al. Anti-Mullerian hormone-a poor assay reproducibility in a large cohort subjects suggests sample instability. Hum Reprod 2012;27:3085–91
   PubMed Web of Science ®Google Scholar
• Zhao J, Ng SY, Rivnay B, et al. Serum Anti-Mullerian hormone (AMH) measurement inter-assay agreement and temperature stability. Fertil Steril 2007;88:S1
   PubMed Web of Science ®Google Scholar
• Fanchin R, Méndez Lozano DH, Louafi N, et al. Dynamics of serum anti-Müllerian hormone levels during the luteal phase of controlled ovarian hyperstimulation. Hum Reprod 2005;20:747–51
   PubMed Web of Science ®Google Scholar
• van Disseldorp J, Lambalk CB, Kwee J, et al. Comparison of inter- and intra-cycle variability of anti-Mullerian hormone and antral follicle counts. Hum Reprod 2010;25:221–7
   PubMed Web of Science ®Google Scholar
• Fleming R, Fairbairn C, Blaney C, et al. Stability of AMH measurement in blood and avoidance of proteolytic changes. Reprod Biomed Online 2013;26:130–2
   PubMed Web of Science ®Google Scholar